Dual Role of alpha6beta4 integrin in epidermal tumor growth: tumor-suppressive versus tumor-promoting function.
An increased expression of the integrin alpha6beta4 is correlated with a poor prognosis in patients with squamous cell carcinomas. However, little is known about the role of alpha6beta4 in the early stages of tumor development. We have isolated cells from mouse skin (mouse tumor-initiating cells [mTICs]) that are deficient in both p53 and Smad4 and carry conditional alleles of the beta4 gene (Itgb4). The mTICs display many features of multipotent epidermal stem cells and produce well-differentiated tumors after subcutaneous injection into nude mice. Deletion of Itgb4 led to enhanced tumor growth, indicating that alpha6beta4 mediates a tumor-suppressive effect. Reconstitution experiments with beta4-chimeras showed that this effect is not dependent on ligation of alpha6beta4 to laminin-5, but on the recruitment by this integrin of the cytoskeletal linker protein plectin to the plasma membrane. Depletion of plectin, like that of beta4, led to increased tumor growth. In contrast, when mTICs had been further transformed with oncogenic Ras, alpha6beta4 stimulated tumor growth, as previously observed in human squamous neoplasms. Expression of different effector-loop mutants of Ras(V12) suggests that this effect depends on a strong activation of the Erk pathway. Together, these data show that depending on the mutations involved, alpha6beta4 can either mediate an adhesion-independent tumor-suppressive effect or act as a tumor promotor.
Raymond
Karine
K
Division of Cell Biology and Experimental Animal Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Kreft
Maaike
M
Song
Ji-Ying
JY
Janssen
Hans
H
Sonnenberg
Arnoud
A
D000483:Alleles; D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D003896:Desmosomes / Q000378:metabolism; D004789:Enzyme Activation; D004817:Epidermis / Q000378:metabolism* / Q000473:pathology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D039161:Integrin alpha6beta4 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D046529:Microscopy, Electron, Transmission; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D051190:Plectin / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding; D034622:RNA Interference; D013234:Stem Cells / Q000166:cytology / Q000378:metabolism; D018631:ras Proteins / Q000235:genetics
D039161:Integrin alpha6beta4; D051190:Plectin; D048049:Extracellular Signal-Regulated MAP Kinases; D018631:ras Proteins
Nat Cell Biol. 1999 Jul;1(3):158-64
10559902
Cell. 1997 May 2;89(3):457-67
9150145
FASEB J. 2000 Apr;14(5):752-60
10744631
J Cell Biol. 2000 May 15;149(4):969-82
10811835
Methods Enzymol. 2001;333:343-8
11400350
J Biol Chem. 2001 Sep 14;276(37):35123-32
11445569
Arch Dermatol. 2001 Nov;137(11):1458-61
11708948
Nat Genet. 2001 Dec;29(4):418-25
11694875
J Invest Dermatol. 2001 Dec;117(6):1405-11
11886501
Science. 2002 Apr 19;296(5567):550-3
11910072
Nat Rev Cancer. 2002 May;2(5):331-41
12044009
Biochem Biophys Res Commun. 2002 Aug 30;296(4):904-10
12200133
Mol Biol Cell. 2002 Nov;13(11):3845-58
12429829
Nature. 2003 Feb 6;421(6923):639-43
12571598
Nat Rev Cancer. 2003 Jun;3(6):444-51
12778134
J Cell Biol. 2003 Nov 10;163(3):609-23
14610062
Science. 2004 Jan 16;303(5656):359-63
14671312
Cell. 2004 Mar 19;116(6):769-78
15035980
Nat Biotechnol. 2004 Apr;22(4):411-7
15024388
J Biol Chem. 2004 Apr 30;279(18):18701-10
14966116
Genesis. 2004 May;39(1):10-25
15124223
Development. 2004 May;131(10):2257-68
15102710
Carcinogenesis. 1983 Nov;4(11):1367-77
6196137
J Cell Biol. 1986 Dec;103(6 Pt 2):2593-606
2432071
Differentiation. 1987;35(3):236-48
2451629
J Invest Dermatol. 1992 Jan;98(1):24-32
1728637
Cancer Res. 1993 Oct 15;53(20):4803-10
8402665
J Cell Sci. 1993 Dec;106 ( Pt 4):1083-102
8126093
J Biochem. 1994 Mar;115(3):469-76
8056759
Cancer Res. 1995 Nov 15;55(22):5434-44
7585613
Dev Dyn. 1996 May;206(1):12-23
9019243
Genes Dev. 1998 Nov 1;12(21):3442-51
9808630
J Invest Dermatol. 1999 Apr;112(4):411-8
10201522
Matrix Biol. 1999 Feb;18(1):19-28
10367728
Dev Biol. 1999 Aug 15;212(2):278-89
10433821
J Cell Biol. 1999 Sep 6;146(5):1147-60
10477766
J Cell Sci. 2005 Mar 1;118(Pt 5):1045-60
15731010
Mol Cell Biol. 2005 Jul;25(14):6090-102
15988021
Cancer Res. 2005 Oct 1;65(19):8671-8
16204035
Cell. 1997 Dec 26;91(7):949-60
9428518
EMBO J. 1998 Jun 1;17(11):3091-100
9606191
Cancer Metastasis Rev. 2005 Sep;24(3):413-23
16258729
Nat Rev Cancer. 2005 Nov;5(11):899-904
16327766
Nat Med. 2005 Dec;11(12):1351-4
16288281
Oncogene. 2006 Jan 12;25(2):207-17
16170355
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2322-7
16452166
Mol Cell Biol. 2006 Apr;26(8):2877-86
16581764
J Cell Sci. 2006 May 1;119(Pt 9):1864-75
16608880
Trends Cell Biol. 2006 Jul;16(7):376-83
16757171
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10063-8
17553962
J Cell Biol. 1998 Oct 19;143(2):469-86
9786956
Science. 1997 Mar 21;275(5307):1784-7
9065401
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2386-91
9122204
Differentiation. 1997 Feb;61(3):187-94
9084137
J Cell Biol. 1999 Nov 29;147(5):1063-72
10579725